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Presenilin 1 (PS1) regulates environmental enrich-
ment (EE)-mediated neural progenitor cell (NPC)
proliferation and neurogenesis in the adult hippo-
campus. We now report that transgenic mice that
ubiquitously express human PS1 variants linked to
early-onset familial Alzheimer’s disease (FAD) neither
exhibit EE-induced proliferation, nor neuronal line-
age commitment of NPCs. Remarkably, the prolifera-
tion and differentiation of cultured NPCs from
standard-housed mice expressing wild-type PS1 or
PS1 variants are indistinguishable. On the other
hand, wild-type NPCs cocultured with primary mi-
croglia from mice expressing PS1 variants exhibit
impaired proliferation and neuronal lineage commit-
ment, phenotypes that are recapitulated with mutant
microglia conditioned media in which we detect
altered levels of selected soluble signaling factors.
These findings lead us to conclude that factors
secreted from microglia play a central role in
modulating hippocampal neurogenesis, and argue
for non-cell-autonomous mechanisms that govern
FAD-linked PS1-mediated impairments in adult
hippocampal neurogenesis.
INTRODUCTION
Alzheimer’s disease (AD), a progressive neurodegenerative dis-
ease, is characterized by deterioration of cognitive function,
neuronal loss, and deposition of b-amyloid (Ab) peptides. Ab
peptides are liberated from larger transmembrane amyloid
precursor proteins (APP) by the concerted action of BACE 1
and g-secretase. Familial, early-onset, autosomal-dominant568 Neuron 59, 568–580, August 28, 2008 ª2008 Elsevier Inc.forms of AD (FAD) are caused by expression of mutant genes en-
coding presenilin 1 (PS1), presenilin 2 (PS2), and APP. While the
molecular mechanism(s) by which expression of mutant PS1
polypeptides cause FAD are not fully understood, expression
of these polypeptides enhances the ratio of Ab42/Ab40 peptides,
leading to selective deposition of the Ab42 peptides in amyloid
plaques (Selkoe, 1998).
PS1 is the catalytic component of a multisubunit complex,
termed g-secretase, that is responsible for the intramembranous
proteolysis of several type I membrane proteins, including APP
and Notch-1 (for review, see De Strooper, 2003; Sisodia and
St George-Hyslop, 2002). PS1 also plays a role in aspects of
neurogenesis both during development and in the adult: PS1-
deficient mice exhibit precocious proliferation of neural progen-
itors in the central nervous system (CNS), leading to reductions
in cortical neurons (Handler et al., 2000; Shen et al., 1997); and
enrichment-mediated hippocampal neurogenesis is impaired in
adult mice with conditionally deleted PS1 alleles in the forebrain
(Feng et al., 2001).
It is now well accepted that proliferation of neuronal progen-
itors occurs in the adult CNS, and primarily, if not exclusively, in
the subgranular layer (SGL) of the dentate gyrus (DG) and the
anterior part of the subventricular zone (SVZ). It has been sug-
gested that neurogenesis in the adult CNS plays a role in learn-
ing and memory, adaptation to novel environments, and injury
or disease (for review, see Lie et al., 2004). Understanding
the role of neurogenesis in these settings is critical, particularly
when considering the impact of aging and neurodegenerative
diseases, such as AD. Numerous studies have suggested that
the rate of neurogenesis in both SVZ and DG declines with
age, raising the possibility that reduced neurogenesis may
account, at least in part, for impaired learning and memory
and cognitive deterioration in the elderly (Kempermann et al.,
1998, 2002; Seki and Arai, 1995; Tropepe et al., 1997). Unfortu-
nately, there is limited information regarding neurogenesis in
AD and transgenic animal models (for review, see van Praag,
2008).
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erties of hippocampal neural progenitor cells (NPCs) are regu-
lated by the combination of both cell intrinsic mechanisms and
changes in local environment. For example, the levels or compo-
sition of chemokines and/or secreted factors within the microen-
vironment have been implicated in hippocampal NPC prolifera-
tion and differentiation (for review, see Nakashima and Taga,
2002). Moreover, glial cells have been implicated in governing
the factors within stem cell niches that influence cell fate com-
mitment of hippocampal progenitors to a neuronal lineage (Lie
et al., 2005; Nakajima and Kohsaka, 2001; Song et al., 2002).
It is now well established that exposure of adult rodents to an
enriched environment (EE) induces neurogenesis in the DG
(Kempermann et al., 1997; van Praag et al., 1999). In this paper,
we employed EE to explore the role of wild-type or two indepen-
dent FAD-linked mutant human PS1 variants in the regulation of
dentate neurogenesis. We now report that EE-induced prolifera-
tion and neuronal differentiation of progenitor cells in the DG of
mice harboring ubiquitously-expressed mouse prion protein
(PrP) promoter-driven transgenes encoding the FAD-linked
PS1DE9 or PS1M146L variants are significantly impaired, com-
pared to mice expressing human wild-type PS1 (PS1hWT).
Moreover, impaired neurogenesis in the DG of mice expressing
FAD-linked PS1 variants is associated with decreased numbers
of activatedmicroglia that populate the hippocampus. Extending
these observations, we show that primary microglia expressing
FAD-linked PS1 or conditioned media from these cells markedly
inhibits proliferation and neuronal lineage commitment of cul-
tured NPCs from wild-type mice and impairs the neurogenetic
potential of newly born progenitors in organotypic slices from
adult wild-type mice. Indeed, we observe considerable differ-
ences in secreted soluble factor profiles between microglia
expressing FAD-linked PS1 variants and PS1hWT, leading us
to conclude that soluble factors released from microglia, at least
in part, are responsible for the defective EE-induced neurogene-
sis observed in FAD-linked PS1 mutant mice.
RESULTS
Expression of FAD-Linked PS1 Variants Impairs
Enrichment-Induced Proliferation of Hippocampal
Progenitor Cells
It is well established that exposure of adult rodents to an EE
induces neurogenesis in the DG (Kempermann et al., 1997; van
Praag et al., 1999). To determine whether FAD-linked mutant
PS1 affects proliferation of progenitor cells, we examined trans-
genic mice harboring mouse PrP promoter-driven transgenes
that encode either PS1hWT or the FAD-linked PS1DE9 and
PS1M146L variants (Borchelt et al., 1996b; Lee et al., 1997).
We established that the polypeptides expressed by each trans-
gene were ubiquitously expressed and overlapping patterns in
brain (see Figure S1 available online).
Mice were either exposed to EE (termed ‘‘enriched’’ mice) for
3 hr a day for 1 month or maintained in standard housing condi-
tions (termed ‘‘standard’’ mice) for 1 month. At the end of 1
month, standard housed mice or their ‘‘enriched’’ counterparts
were injected with a single dose of BrdU. Mice were sacrificed
24 hr postinjection, and brain sections were subject to immuno-cytochemical analysis using a BrdU-specific antibody; the
number of BrdU-positive cells in the SGL and granule cell layers
(GCL) was quantified by stereological methods.
We failed to observe any significant difference in the numbers
of BrdU-positive cells in the DG of mice expressing PS1hWT or
either of the FAD-linked PS1 variants that were maintained in
standard housing conditions (Figure 1, compare panel A versus
B and C, respectively; quantified in Figure 1G, first left panel). As
expected, we observed a marked increase in the number of
BrdU-positive cells in the enriched PS1hWT mice (Figure 1D)
compared to standard PS1hWT mice (Figure 1A). Remarkably,
we observed that enriched mice expressing the human PS1
variants failed to elicit an enhancement in the number of BrdU-
positive cells in the DG (compare Figures 1B and 1E, and Figures
1C and 1F). These data indicate that EE-mediated enhancement
of progenitor cell proliferation in the DG is significantly attenu-
ated by the expression of two independent FAD-linked PS1
variants.
We extended the latter observations to quantify the absolute
number of granule cells in the DG of mice housed in either stan-
dard conditions or exposed to EE (Figure 1H). We did not find
significant differences in granule cell numbers between the three
transgenic lines maintained in standard housing or enriched
conditions (Figure 1H). However, and in view of earlier studies
showing that running is critical for enhancing NPC proliferation
(van Praag et al., 1999), we examined granule cell numbers in
the DG of mice that spent over 40% of their enrichment time
on the running wheels (‘‘highly active mice’’) and observed that
these PS1hWT mice contained, on average, greater than
270,000 granule cells, as opposed to approximately 240,000
granule cells in standard PS1hWT mice. On the other hand,
mice expressing the PS1 variants that were ‘‘highly active’’
showed only a modest increase in total number of granule cells
compared to standard housed mice and significantly lower
than the numbers of dentate granule cells in ‘‘highly active’’
PS1hWT mice (Figure 1H).
To assess the specificity of the enrichment paradigm in medi-
ating hippocampal NPC proliferation, we assessed the impact of
expressing PS1hWT and the FAD-linked PS1 mutants on NPC
proliferation in the SVZ, a neurogenic niche that is not subject
to enrichment or running-mediated proliferation of NPCs. NPC
proliferation in the SVZ of PS1hWT or FAD-linked PS1 mutant
mice is unchanged following enrichment (Figure S2A).
Finally, we tested the possibility that the impact of the PS1
variants on NPC proliferation may be mediated by the presence
of Ab peptides or toxic Ab oligomers that might be generated as
a consequence of PS1 mutant-mediated elevation in Ab42/40
ratios. For these studies, we crossed the PS1hWT or PS1DE9
mice with APP-deficient mice (APP KO mice; Zheng et al.,
1995). We did not observe any significant differences in NPC
proliferation among the PS1hWT/APPKO or PS1DE9/APPKO
strains that were exposed to standard housing conditions
(Figure S2B). More importantly, we neither observed significant
differences in NPC proliferation between enriched PS1hWT
and enriched PS1hWT/APPKO mice, nor between enriched
PS1DE9 and enriched PS1DE9/APPKO mice. We conclude
that the impaired NPC proliferation in mice expressing PS1
variants is independent of APP expression.Neuron 59, 568–580, August 28, 2008 ª2008 Elsevier Inc. 569
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Presenilin 1 Variants Impair Adult NeurogenesisFigure 1. Expression of FAD-Linked PS1 Variants Impairs Enrichment-Induced Proliferation of Hippocampal Neural Progenitors
(A–F) Photomicrographs of BrdU (green or yellow)+ cells in the DG of PS1hWT (A and D), PS1DE9 (B and E) and PS1M146L (C and F). SH, standard housing
conditions (A, B, and C); EE, enriched conditions (D, E, and F). NeuN, red. Scale bar: 100 mm.
(G) Quantification of BrdU+ cells (mean ± SEM; n = 10–15 per group). *p < 0.05.
(H) Quantification of granule cell number. *p < 0.05.
(I) Photomicrograph of primary neurospheres. Scale bar: 50 mm.
(J) Image of nestin (green)+ neurosphere. Scale bar: 25 mm.
(K) Nuclei were stained with DAPI (blue).
(L) Percentage of multipotent neurospheres obtained in clonogenic neurosphere assay (mean ± SEM, n = 5 animals per group). **p < 0.01.Expression of FAD-Linked PS1 Variants Impairs
EE-Induced Clonal Proliferation of Hippocampal
Progenitor Cells in In Vitro Neurosphere Assays
NPCs from hippocampus and other neurogenic regions of the
adult mammalian brain can be isolated and grown in vitro as
clonal sphere-forming cell colonies, termed neurospheres (Bull
and Bartlett, 2005; Hitoshi et al., 2002). We cultured hippocam-
pal NPCs from 4- to 8-week-old male transgenic lines express-
ing PS1hWT or PS1 variants exposed to standard or enriched
housing conditions (Figures 1I–1K). Western blot analysis of
detergent-solubilized lysates confirmed that the transgenes
expressed the human PS1 polypeptides in NPCs (Figure S3A).
No significant changes were observed in the percentage
(0.14%; 1 in every 6–8 3 103 cells) of neurospheres that ap-
peared in cultures derived from each standard housed trans-
genic line (Figure 1L, left panel). However, a significant increase
in the percentage of neurospheres was observed in the cell prep-
arations derived from enriched PS1hWT mice (Figure 1L, right
panel), findings fully consistent with the in vivo BrdU labeling
studies (Figure 1G). More importantly, we did not observe an570 Neuron 59, 568–580, August 28, 2008 ª2008 Elsevier Inc.elevation in the fraction of neurospheres derived from plated
populations of cells from hippocampi of enriched mice express-
ing the PS1 variants compared to their standard housed
littermates (Figure 1L, right panel).
Collectively, our studies argue that the enrichment paradigm
induces proliferation of progenitor cells in the hippocampus
of PS1hWT mice and that this phenomenon is attenuated by
expression of two independent FAD-linked PS1 variants.
FAD-Linked PS1 Mutants Affect Neuronal
Differentiation of Progenitor Cells in the DG
To determine whether FAD-linked PS1 variants affect the differ-
entiation of newly-born progenitors, we performed double or
triple labeling studies using anti-BrdU antibodies combined
with antibodies specific for neuronal or glial lineages, 2 weeks
after BrdU injection (Figure 2). We examined expression of the
following markers: doublecortin (DCX), a marker of early neuro-
nal differentiation; bIII-tubulin (TUJ1), a marker of both early
and mature neurons; NeuN, a neuron-specific nuclear antigen
associated with mature granule cells; glial fibrillary acidic protein
Neuron
Presenilin 1 Variants Impair Adult NeurogenesisFigure 2. FAD-Linked PS1 Mutants Alter Differentiation Pattern of Neural Progenitors
(A–E) Images of BrdU+ cells that are colabeledwith either DCX (A), bIII-tubulin (B), NeuN (C), GFAP (D), or s100b (E). Scale bar: 50 mm (A, B, D, and E) or 100 mm (C).
(F, H, J, L, and N) The fraction of BrdU+ cells that expressed DCX (F), bIII-tubulin (H), NeuN (J), GFAP (L), or s100b (N).
(G, I, K, M, and O) The number of new DCX (G), bIII-tubulin (I), NeuN (K), GFAP (M), or s100b (O) cells. *p < 0.05; **p < 0.01. n = 8 per group.(GFAP) and s100b, astrocyte-specific markers. The numbers of
new DCX-, bIII-tubulin-, NeuN-, GFAP- or s100b-labeled cells
were determined by multiplying the number of surviving BrdU-
labeled cells by the fraction of cells that expressed each marker
(Figures 2G, 2I, 2K, 2M, and 2O). Standard mice expressing ei-
ther PS1hWT or FAD-linked PS1 variants did not show any differ-
ences in the levels of differentiated cell types derived from newly
born progenitors. Quantification of BrdU-positive cells that are
also DCX-positive revealed that both the fraction (Figure 2F)
and the total number (Figure 2G) of colabeled cells were signifi-
cantly lower in enrichedmice expressing either of the FAD-linked
PS1 variants compared to PS1hWT mice. Moreover, there ap-
pears to be a significantly lower fraction (Figure 2H) and number
(Figure 2I) of BrdU-labeled cells that are immunopositive for bIII-
tubulin within the DG of mice expressing the PS1 variants com-
pared to PS1hWTmice. While we did not observe any difference
in the fraction of BrdU- and NeuN-positive neurons between
mice expressing PS1hWT and PS1DE9 (Figure 2J), the number
of BrdU- and NeuN-positive neurons in the DG of mice express-
ing PS1DE9 is significantly reduced compared to PS1hWT
(Figure 2K). Collectively, these data indicate that both themutant
PS1 lines produced significantly fewer neurons from newly gen-erated NPCs compared to the PS1hWT mice. We also observed
that only a minor fraction of BrdU-positive cells were colabeled
with GFAP (Figure 2L) or s100b (Figure 2N), and we found no
significant differences between the groups. However, while there
appears to be more GFAP and s100b cells produced in the
enriched PS1hWT mice compared to the other five groups
(Figures 2M and 2O, respectively), only the differences in
GFAP cell numbers reached statistical significance (Figure 2M).
FAD-Linked PS1 Mutant Mice Fail to Exhibit High
Activity-Induced Increases in Microglial Cell Numbers
Recent studies have revealed a pivotal role for microglia in acti-
vation and maintenance of adult hippocampal neurogenesis in
rodents following exposure to EE conditions (Ziv et al., 2006).
The fact that the PrP promoter-driven PSEN1 transgenes are
ubiquitously expressed in neuronal and nonneuronal cells
(Figure S1) in the CNS prompted us to examine the influence
of EE on microglia expressing FAD-linked PS1 variants. For
these studies, we employed the microglial markers, Isolectin
B-4 (IB-4; Figures 3A, 3D, and 3G) and Iba1 (Figures 3B, 3E,
and 3H). Notably, IB-4 detects microglia and endothelial cells
(Streit and Kreutzberg, 1987); see our Figure 3J (arrow) andNeuron 59, 568–580, August 28, 2008 ª2008 Elsevier Inc. 571
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Presenilin 1 Variants Impair Adult NeurogenesisFigure 3. FAD-Linked PS1 Mutant Mice Fail to Exhibit High Activity-Induced Increase in Microglial Cell Numbers
(A–L) Images of microglia in DG of standard PS1hWT (A, B, and C), highly active PS1hWT (D, E, and F), highly active PS1M146L (G, H, and I), and highly active
PS1hWT (highmagnification; J, K, and L). Microglia are labeled with IB-4 (green; A, D, G, and J) and Iba1 (red; B, E, H, and K). Merged images are shown in (C), (F),
(I), and (L). Scale bars: 100 mm in (A); 50 mm in (J).
(M) Quantification of Iba1+ cells in standard or enriched PS1hWT and FAD-linked PS1 variants (mean ± SEM; n = 10–15 per group).
(N) Quantification of Iba1+ cells in highly active or low active PS1hWT and FAD-linked PS1 variants. *p < 0.05.compare to Iba1 immunoreactive profile in Figure 3K. Further,
the signal observed with IB-4 was very weak compared to Iba1
staining (compare Figures 3D and 3E) and was prominent in
samples that showed strong Iba1 immunoreactivity (compare
Figures 3D with Figures 3A or 3G). To avoid issues with regard
to specificity and signal to noise, we chose to count Iba1-posi-
tive microglial cells in the hilus, SGL, and GCL (Figures 3B, 3E,
and 3H). We did not find any significant differences in microglia
numbers between the standard housed or enriched lines ex-
pressing either PS1hWT or PS1 variants (Figure 3M). However,
we observed a significant increase in the number of Iba1-positive
microglia in the DG of highly active PS1hWTmice in the enriched
group compared to enriched, but low active, PS1hWT mice
(Figure 3N). More importantly, the number of Iba1-positive mi-
croglia in the DG of highly active FAD-linked PS1 variants was
significantly lower than highly active PS1hWT mice (Figure 3N).
We then examined whether there might be potential differences
in proliferation of microglia in the DG by performing double label-
ing for BrdU and Iba1 but found no significant differences among
all the groups (data not shown).572 Neuron 59, 568–580, August 28, 2008 ª2008 Elsevier Inc.Microglia Expressing FAD-Linked PS1 Variants Impairs
Proliferation of NPCs in In Vitro Coculture Assays
We considered the possibility that microglia from mice express-
ing mutant PS1 may have differential responses to pro- or anti-
inflammatory processes that occur as a consequence of EE
that may, in turn, affect the proliferation or cell fate determination
of neural progenitors in vivo. Thus, we chose to extend our in vivo
observations by testing the ability of cultured primary microglia
from mice expressing PS1hWT or PS1 variants to differentially
regulate the proliferation of hippocampal-derived NPCs
in vitro. We first measured the basal proliferation of NPCs cul-
tured from the hippocampi of 4- to 8-week-old mice expressing
PS1hWT or PS1 variants. Single-cell suspensions of primary
neurospheres were incubated with BrdU, and proliferation was
determined by measuring BrdU incorporation over 6 days using
an ELISA-based assay. We failed to observe any significant dif-
ferences in the proliferation rates between NPCs expressing
PS1hWT or PS1 variants (Figure 4A). In view of these findings,
the observed increase in percentage of neurosphere-forming
cells from PS1hWT mice following enrichment (Figures 1L,
Neuron
Presenilin 1 Variants Impair Adult NeurogenesisFigure 4. Microglia Expressing FAD-Linked PS1 Variants Impair Proliferation of NPCs in In Vitro Coculture Assays
(A) Proliferation achieved by NPCs, expressing PS1hWT, PS1DE9 or PS1M146L, grown in SFM supplemented with BrdU (mean ± SEM from a minimum of three
experiments per group).
(B–D) IB-4+microglial cells (B, green) and nestin+ NPCs (C, red) under coculture conditions. Themerged image is shown in (D). Fibrillar staining of the intermediate
filament protein, Nestin, is evident on NPCs (arrowhead) but not on microglial cells (arrow). Scale bar: 10 mm.
(E and F) Proliferation of PS1hWT NPCs when cocultured with AraC-treated resting (E) or IL-4-activated (F) microglia (MG) expressing PS1hWT, PS1DE9, or
PS1M146L as measured by BrdU labeling. ** indicates significant difference from PS1hWT MG at p < 0.01 on day 3 or 6.
(G–J) Confocal z series reconstructed image of cells stained with IB-4 (G), anti-nestin (H), anti-BrdU antibody (I), and DAPI (J), following 6 days under coculturing
conditions.
(K–N) Confocal images of a single z plane within nestin+ neural progenitor cluster (K, red, arrowhead) reveals several BrdU+ progenitors (K, cyan blue, enclosed
within circle) and an IB-4+ MG (K, green, arrow). Insert shows the zoom-in area marked within dotted square (L). Scale bar: 50 mm.
(M and N) Zoomed images of cells that are colabeled with BrdU/nestin (M) or BrdU/IB-4 (N). Scale bar: 10 mm.
(O and P) Quantification of BrdU and nestin (O) or BrdU and IB-4 (P) colabeled cells in the coculture assay. The asterisk indicates significant difference from
PS1hWT MG at *p < 0.05 and **p < 0.01.above) is not because of inherent differences in the rates of
proliferation of NPCs in vitro but rather reflects an overall
increase in the size of the neural progenitor pool in vivo.
We then chose to examine the potential role of microglia in
NPC proliferation using a coculture assay that employed primary
microglial cultures from hippocampi of neonatal transgenic pups
(Figures S4A and S4B). The expression of PrP promoter-driven
human PS1 transgenes were confirmed in microglia cultures
(Figure S3B), and these findings mirrored the results observed
with primary NPC cultures (Figure S3A). Previous studies have
suggested that depending on the physiological stimuli, microglia
can differentially influence the fate of NPCs in culture (Butovsky
et al., 2006). In particular, priming cultured microglia with a
T-helper cell type 2 (TH-2)-derived cytokine, interlukin-4 (IL-4),
promotes neuroprotective and anti-inflammatory phenotypeof microglia. Protection by IL-4 has been partly attributed to
increased production of insulin-like growth factor 1 (IGF-1),
a growth factor that has been linked with adult neurogenesis
(Anderson et al., 2002; Trejo et al., 2001). Notably, the phenotype
of neuroprotective microglia observed in the DG of rodents
housed in the EE resembles that of IL-4-primed cultured micro-
glia that express IGF-1 (Ziv et al., 2006). With these observations
in mind, we examined the effects of microgila expressing
PS1hWT and PS1 variants on proliferation of neural progentiors
cultured under resting conditions or after priming with IL-4.
Treatment of PS1hWTmicroglia with IL-4 led to their activation,
as confirmed by an increase in the Iba1 expression (Figure S4B,
compare panels iii and iv). In addition, IL-4-treated microglia
also induced IGF-1 transcript levels (Figure S4C), providing evi-
dence that the activated microglia used in our studies exhibitNeuron 59, 568–580, August 28, 2008 ª2008 Elsevier Inc. 573
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Presenilin 1 Variants Impair Adult NeurogenesisFigure 5. ConditionedMedia fromMicroglia
Expressing FAD-Linked PS1 Variants Impair
Proliferation of Neural Progenitors
(A and B) Proliferation achieved by PS1hWT NPCs
following treatment with conditioned media col-
lected from resting (A) or IL-4-activated (B) micro-
glia (MG) expressing mentioned PS1 transgenes,
as measured by BrdU labeling. ** indicates signif-
icant difference from PS1hWT MG media at p <
0.01 on day 3 or 6.neuroprotective, anti-inflammatory microglial phenotypes (Ziv
et al., 2006). Induction of IGF-1 was accompanied by an increase
in transcripts encodingarginase-1 (FigureS4D),previously shown
to be induced by IL-4-mediated activation of the IL-4 receptor
(Gray et al., 2005; Pauleau et al., 2004;Wynes and Riches, 2003).
In coculture assays, we used the BrdU-uptake assay to exam-
ine the proliferation of NPC expressing PS1hWT in the presence
of resting (Figure 4E) or IL-4-activated (Figure 4F) microglia de-
rived from mice expressing either PS1hWT or PS1 variants
(Figure 4A). Prior to coculture, the enriched microglial cell prep-
arations were treated with irreversible cell cycle inhibitor, AraC,
in order to arrest their growth. Representative photomicro-
graphs, shown in Figures 4B–4D, reveal the existence of nes-
tin-positive NPCs with IB-4-positive microglia in these coculture
assays. While the extent of BrdU incorporation was similar
across all NPC-microglia coculture combinations at 1 day, the
proliferation of PS1hWT expressing NPC was significantly re-
tarded at days 3 and 6 in the presence of resting or IL-4-treated
microglia that were derived from neonatal pups expressing PS1
variants (Figures 4E and 4F). To verify that BrdU incorporation
was selective for NPCs, we immunostained fixed cocultures
with IB-4, nestin, and BrdU antibodies. Immunofluorescence mi-
croscopy revealed that the majority of BrdU-positive cells within
the neural progenitor cluster following 6 days in coculture condi-
tions were within the neurosphere (Figure S5). Confocal laser z
series image reconstruction of these cocultures revealed distinct
staining of IB-4-positive microglial cells (Figures 4G) within the
nestin (Figure 4H) and BrdU-positive (Figure 4I) neural progenitor
cluster. Neural progenitors colabeled with nestin and BrdU (Fig-
ures 4K and 4M), and microglia colabeled with IB-4 and BrdU
(Figures 4N) were identified from each focal plane and quantified
by sampling a minimum of five size-matched neural progenitor
clusters and 200 IB-4-positive microglial cells, respectively.
Quantification of cells colabeled with BrdU and nestin revealed
that proliferation of PS1hWT NPC was significantly inhibited on
days 3 and 6 when cocultured with microglia expressing PS1
variants (Figure 4O). BrdU and IB-4 staining revealed no signifi-
cant differences across the genotypes over the 6 day period
(Figure 4P). Thus, our microscopic colabeling studies reveal
that the vast majority of BrdU-labeled cells in the NPC-microglial
cocultures are the NPCs. More importantly, these data fully sup-
port our ELISA-based BrdU-incorporation assays (Figures 4E
and 4F) and argue that expression of FAD-linked PS1 variants
impair proliferation of NPCs expressing PS1hWT.574 Neuron 59, 568–580, August 28, 2008 ª2008 Elsevier Inc.Conditioned Media from Microglia Expressing
FAD-Linked PS1 Variants Impairs Proliferation of NPCs
in In Vitro Assays and in Organotypic Slice Cultures
Extending the coculture studies, we chose to ask whether fac-
tors secreted by microglia may be involved in regulating prolifer-
ation of NPC. For these studies, we measured the growth rate of
NPCs expressing PS1hWT that were exposed to conditioned
media (CM) collected from resting (Figure 5A) or IL-4-activated
(Figure 5B) microglial cells derived from neonatal mice express-
ing PS1hWT or PS1 variants. By day 1 and 3, the extent of BrdU
incorporation was similar across NPCs treated with CM col-
lected from resting microglia from each of the lines, but by day
6, proliferation of NPC was significantly retarded in the presence
of CM frommicroglia that express PS1DE9 (Figure 5A). Likewise,
significant retardation in NPC proliferation was observed by day
6 when exposed to CM collected from IL-4-activated microglia
expressing both PS1 variants, but not PS1hWT (Figure 5B).
These studies lead us to conclude that the pronounced effects
of microglia expressing PS1 mutants on NPC proliferation can
be attributed to factors secreted by the mutant PS1 microglia.
To investigate whether secreted factors from PS1 mutant micro-
glia could affect NPC proliferation in a more physiological set-
ting, we employed organotypic slice cultures (Figure S6; Namba
et al., 2007; Raineteau et al., 2004; Tozuka et al., 2005). In this
setting, we demonstrate that in contrast to slices treated with
resting or IL-4-activated PS1hWT microglia CM, the percentage
of BrdU- and DCX-labeled NPCs per total BrdU-labeled cells
were significantly reduced when the slices were exposed to rest-
ing or IL-4-activated CM collected from PS1DE9 microglia
(Figure S6). Collectively, these data indicate that soluble factors
secreted from PS1DE9 microglia impair proliferation of PS1hWT
NPCs in in vitro primary culture studies and in ex vivo organo-
typic slice cultures.
Factors Secreted from Activated Microglia Expressing
FAD-Linked PS1 Mutants Impairs In Vitro Neuronal
Differentiation of NPCs
We sought to determine whether FAD-linked PS1 variants affect
the intrinsic differentiation potential of cultured neural progeni-
tors by differentiating single cell suspensions of primary neuro-
spheres derived from mice expressing PS1hWT or PS1 variants
by supplementing the medium with 3% fetal bovine serum. After
10 days, fixed cells were immunostained with antibodies that
detect neurons (bIII-tubulin), oligodendrocytes (O4), astrocytes
Neuron
Presenilin 1 Variants Impair Adult NeurogenesisFigure 6. Differentiation Pattern of Cultured
NPCs Is Modulated by FAD-Linked PS1
Mutant Expressing Microglia
(A) Progeny cell types generated by NPCs in the
multipotency assay were quantified by sampling
a minimum of 300 cells as marked by DAPI or pro-
pidium iodide+ nuclei (mean ± SEM of the results
obtained from independent cultures established
from six animals per group).
(B) Fold changes in the number of bIII-tubulin+
neuronal or GFAP+ astrocyte progeny cell type
derived from PS1hWT NPCs exposed to CM col-
lected from resting or IL-4-activated MG, over dif-
ferentiated PS1hWT NPC cultures in the absence
of MG CM (mean ± SEM; n = 6). The asterisk indi-
cates significant difference from PS1hWT MG CM
at *p < 0.05 and **p < 0.01.(GFAP), or astroglia (s100b) (Figures S7A–S7D). Across all the
tested genotypes, quantitative analysis revealed 4.5% to 6%,
1% to 2%, 24% to 27%, and 27% to 30% of the sampled cells
in each culture were positive for bIII-tubulin, O4, GFAP, and
s100b lineage markers, respectively (Figure 6A). Importantly,
we did not observe any significant differences in distinct line-
age-specific differentiation of NPCs that express either PS1hWT
or FAD-linked PS1 variants.
We then investigated whether the in vitro differentiation pat-
tern of NPCs expressing PS1hWT could be modulated by solu-
ble factors secreted by resting or IL-4-activated microglia from
mice expressing either PS1hWT or PS1 variants. PS1hWT
NPCs were treated with CM for 12 days, fixed, and subject to
indirect immunofluorescence microscopy assess commitment
toward bIII-tubulin-positive or GFAP-positive lineages (see
Figure S7E). Quantitative analysis showed no significant differ-
ences in the differentiation pattern of PS1hWT NPCs when
exposed to CM collected from resting microglia that express
either PS1hWT or PS1 variants (Figure 6B). On the other hand,
we observed an 2.4-fold increase in the number of bIII-tubu-
lin-positive cells when NPCs were exposed to CM collected
from IL-4-activated PS1hWT microglia (Figure 6B, left panel),
but only an 1.5-fold increase in bIII-tubulin-positive cells
when NPCs were exposed to CM from IL-4-activated microglia
expressing the PS1 variants. Interestingly, in comparison with
CM collected from PS1hWT microglia, PS1M146L expressing
microglia media were significantly more potent in driving NPC
differentiation toward astrocytes (Figure 6B, right panel).The
data obtained from CM studies indicate that IL-4-activated
FAD-linked PS1 expressing microglia fail to sustain differentia-
tion of NPCs toward the neurogenic fate but promote differenti-
ation toward the astrocyte lineage in in vitro multipotency
assays.
Differences in the Profile of Secreted Signaling Proteins
in PS1hWT and FAD-Linked PS1 Variant Microglia
As it is well established that microglia secrete a variety of cyto-
kines and other soluble factors, including endotoxins and che-
mokines, in response to physiological stimuli, we then examined
the relative levels of 62 different cytokines and secreted signaling
factors in the CM collected from resting or IL-4-activated micro-glial cultures using a biotin-label based protein antibody array
(Figure 7A; Lin et al., 2003). Analysis of protein array profiles re-
vealed that the signal intensity was below detectable threshold
for about 24% of candidate proteins. Of the detectable candi-
dates, 58% revealed no change in signal intensity. Interestingly,
in comparison with the levels observed in resting or IL-4-acti-
vated PS1hWT microglia CM, less than 11% of the candidate
proteins revealed reproducible increases or decreases in ex-
pression levels of at least 1.4-fold in the CM from the PS1
variants (Figure 7B; see list in Table S1).
TIMP-1 (a protease inhibitor—tissue inhibitor of metallopro-
tease), RANTES (a chemokine—regulated upon activation,
normal T cell expressed, and secreted, or CCL5), CXCL1 (a small
cytokine—chemokine CXC ligand 1), IL-6 (a proinflammatory
cytokine—interlukin-6) and IGFBP-6 (Insulin like growth factor
binding protein) were consistently elevated in CM collected
from resting microglia expressing PS1 variants (Figure 7B, upper
panel). Interestingly, in addition to TIMP-1, RANTES and IGFBP-
6, several other soluble signaling factors like CXCL16 (a cyto-
kine—chemokine CXC ligand 16), Eotaxin (a chemokine) and
Leptin (a protein hormone) were increased in CM from IL-4-acti-
vated microglia expressing both PS1 variants (Figure 7B, lower
panel).
Increased levels of Fas L and decreased levels of MCP-1
(a chemokine—monocyte chemoattractant protein-1), SDF-1a
(a chemokine—stromal derived factor-1 alpha), and Lymphotactin
were exclusively altered in CM collected from IL-4-primed
PS1DE9microglia (Table S1B). Likewise, elevated levels of IL (in-
terleukin)-1a and IGFBP-6, and lower levels of MCP-5 and IL-17
were unique to CM collected from IL-4-primed PS1M146L
microglia. Several of these factors have been attributed to the
activated status of microglia. It is also worth noting that MCP-1,
SDF-1a, Eotaxin, and TIMPs have been linked to NPC biology
(Belmadani et al., 2006; Cacci et al., 2008; Edman et al., 2008;
Krathwohl and Kaiser, 2004; Nakanishi et al., 2007; Perez-Marti-
nez and Jaworski, 2005; Tran et al., 2004; Vallieres et al., 2002;
Zhang et al., 2007).
We then asked whether we could assess the contributions of
specific factors that exhibited altered levels in the medium of
IL-4-activated microglia expressing PS1 variants on proliferation
of NPCs in vitro. Since the absolute levels of each factor inNeuron 59, 568–580, August 28, 2008 ª2008 Elsevier Inc. 575
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Presenilin 1 Variants Impair Adult NeurogenesisFigure 7. Quantitative Changes in Signaling Factors Secreted by PS1hWT versus FAD-Linked PS1 Variant Expressing Microglia
(A) Images of biotin-label based protein antibody arrays probed with CM collected from resting or IL-4-activated microglia (MG).
(B) Soluble factors whose levels were consistently altered (up or down ‘‘–’’; mean ± SEM of fold changes observed across three experiments). – denotes no
detectable change in mean signal intensity.microglia CMwere not known, PS1hWT NPCs were treated with
1, 5, or 10 ng/ml of purified, biologically active factors, and pro-
liferation was measured over 6 days. Factors were tested indi-
vidually, or in combination and we identified several factors
that strongly inhibited NPC proliferation (see Figures S8 and
S9). Further studies using blocking antibodies or shRNA ap-
proaches are required to fully establish the identity of the critical
factors responsible for the observed outcomes.
Transcripts Encoding Soluble Factors in Cultured
Neonatal and Adult Microglia
To assess potential mechanisms that underlie the alterations in
secreted signaling proteins, we first asked whether these
changes might be reflected in levels of transcripts encoding
these polypeptides. Total RNA, prepared from resting or IL-4-ac-
tivated microglia expressing PS1hWT or PS1 variants were sub-
ject to Q-PCR analysis. Consistent with the protein array studies,
the levels of transcripts encoding TIMP-1, RANTES, IL-6 and
CXCL1 were elevated in resting microglia expressing FAD-linked
PS1 mutants (Table 1A, upper panel). In the case of IL-4-primed
microglia, wewere able to detect an increase in TIMP-1, CXCL16
and Eotaxin transcript levels (Table 1A, lower panel). The levels
of MCP-1 transcripts were remarkably reduced in IL-4-activated
microglia expressing PS1DE9. We then investigated whether the
alterations in a subset of transcripts observed in cultured micro-
glia could be extrapolated to microglia from hippocampi of stan-
dard or enriched adult transgenic mice. Microglia were purified
using a discontinuous percoll gradient method (Cardona et al.,
2006), and transcript levels were examined by Q-PCR analysis.
In comparison to PS1hWT microglia, an increase in TIMP-1
and CXCL1 transcripts were detected in standard housed
PS1DE9 animals (Table 1B, upper panel). Remarkably, in addi-
tion to TIMP-1 and CXCL1, we also detected elevated levels of576 Neuron 59, 568–580, August 28, 2008 ª2008 Elsevier Inc.transcripts encoding Eotaxin, Leptin, CXCL16, RANTES, and
MCP-1 in microglia isolated from enriched PS1DE9 animals
(Table 1B, lower panel). A subset of the transcripts shown to
be elevated in microglia from enriched PS1DE9 mice were also
elevated in microglia from enriched PS1M146L animals (Table
1B, lower panel). Notably, we demonstrate that while enrichment
appears to induce IL-4 signaling in adult microglia expressing
PS1hWT, as revealed by elevated levels of transcripts encoding
arginase-1 and IGF-1 (Figure S10), there appears to be no signif-
icant difference in levels compared to levels in microglia isolated
from enriched PS1mutant animals. These data indicate that IL-4
receptor signaling is intact in adult microglia from enriched mice
expressing either PS1hWT or PS1mutants, findings that confirm
our earlier analysis of IL-4-activated cultured neonatal microglia
(Figures S4C and S4D).
DISCUSSION
We have examined transgenic mice raised in either standard
conditions or exposed to an EE to explore the role of wild-type
or two independent FAD-linked mutant human PS1 variants in
the regulation of hippocampal neurogenesis. Emerging from
these efforts are several novel insights. First, we report that ex-
pression of mouse PrP promoter-driven transgenes expressing
FAD-linked mutant PS1 impairs EE-induced NPC proliferation
and neuronal differentiation in the adult hippocampus. Second,
we show that the proliferation and differentiation of purified
NPCs from adult transgenic mice expressing either PS1hWT or
PS1 variants are indistinguishable, findings which suggest that
these properties of NPCs are dictated by local cues within the
stem cell niche, in vivo. Third, we show that microglia isolated
from neonatal transgenic mice expressing FAD-linked PS1
mutants inhibit proliferation and impair neuronal lineage
Neuron
Presenilin 1 Variants Impair Adult NeurogenesisTable 1. Differences in the Levels of Transcripts Encoding Soluble Factors in Cultured and Adult Microglia Derived from PS1hWT and
FAD-Linked PS1 Variant Transgenic Mice
(A) Threshold PCR cycle Ct value for the genes examined in resting or IL-4-activated cultured neonatal microglia (MG) (mean ± SEM of Ct values
obtained from three independent Q-PCR experiments). Relative fold changes are mentioned within brackets; up ‘‘+’’ or down ‘‘.’’
(B) Fold change in transcript levels for mentioned genes in MG isolated from the hippocampus of adult mutant PS1 over PS1hWT transgenic
animals following exposure to standard (SH) or enriched environment (EE) (mean ± SEM of fold change obtained from three independent Q-PCR
experiments). - denotes not determined.commitment of cultured NPCs in vitro and impairs neuronal dif-
ferentiation of progenitors in ex vivo organotypic slices. Fourth,
we report significant changes in the levels of secreted factors re-
leased by microglia expressing FAD-linked PS1 variants com-
pared to microglia expressing PS1hWT. Indeed, a subset of
purified factors that are elevated in medium of IL-4-activated
mutant microglia resulted in a strong inhibition of NPC prolifera-
tion. Fifth, we demonstrate that the elevated levels of secreted
signaling molecules in medium of PS1 mutant microglia is paral-
leled by elevated steady-state levels of transcripts encoding
these polypeptides. Finally, we document that many of the tran-
scripts observed to be elevated in cultured neonatal microglia
from PS1 mutant mice are also elevated in adult microglia
obtained from PS1 mutant mice following EE. We conclude
that alterations in levels of signaling molecules secreted by mi-
croglia may, at least in part, be responsible for the defective neu-
rogenesis observed with FAD-linkedmutant PS1 in vivo, findings
that support a non-cell-autonomous role for mutant PS1 in
hippocampal neurogenesis.
Despite the strengths of our conclusions, it is notable that our
data on the impact of FAD-linked PS1 on EE-mediated NPC pro-
liferation and neurogenesis are not fully consistent with reports in
the literature that have offered rather differing outcomes. As an
example, Wen et al. (2004) reported that enriched mice express-
ing the PS1M117L variant exhibited elevated levels of cell prolif-
eration in the DG, compared to PS1hWT mice (Wen et al., 2004).The differences in outcomes observed between our laboratory
and those of earlier reports may be a reflection of differences
in methodology, including the enrichment protocol and BrdU in-
jection schedule (for review, see van Praag, 2008). However, we
feel themost salient differences relates to the promoter elements
that drive expression of the PSEN1 transgenes. In the case of the
studies of Wen et al. (2004), the promoter elements were derived
from NSE genes that are preferentially expressed in mature neu-
rons but not NPCs, or nonneuronal cells. In contrast, we have
employed a mouse prion promoter that with the exception of
Purkinje cells, is ubiquitously expressed in both neuronal and
nonneuronal cells in the brain in a pattern that very closely re-
flects the distribution of endogenous mouse PS1 (Borchelt
et al., 1996a). In this regard, it has become increasingly evident
that microglia play a critical role in hippocampal neurogenesis;
in response to physiological stimuli, microglia get activated, pro-
liferate (Ehninger and Kempermann, 2003) and localize in close
proximity to the subgranular zone (stem cell niche) of the DG
(Ziv et al., 2006) where they produce soluble factors that promote
differentiation of neural progenitors (Aarum et al., 2003; Battista
et al., 2006; Nakanishi et al., 2007; Walton et al., 2006). Hence,
we felt it was critical to examine the role of microglia expressing
either PS1hWT or mutant PS1 variants in adult neurogenesis.
Using an established coculture paradigm, we observed that pro-
liferation of cultured PS1hWT NPC was strongly inhibited when
cocultured with resting or IL-4-activated microglia that expressNeuron 59, 568–580, August 28, 2008 ª2008 Elsevier Inc. 577
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expressing PS1 variants also inhibits NPC proliferation and
neuronal differentiation in vitro.
Using a cytokine antibody array assay, we identified quantita-
tive differences in the expression profiles of several secreted
signaling molecules in the CM of IL-4-activated PS1hWT versus
FAD-linked PS1 microglia. For example, RANTES and Eotaxin,
that are elevated in mutant PS1 microglia medium, have been
shown to promote quiescence of cultured human NPCs and pro-
genitor cells in hippocampal slices (Krathwohl and Kaiser, 2004),
while decreased levels of the MCP family members, MCP1 and
MCP5, could result in the impaired infiltration and migration of
microglia into the hippocampus following exposure to enriched
housing conditions. Indeed, we readily observed significant
differences in the numbers of Iba1-positive microglia in the hip-
pocampus of highly active enriched mice expressing PS1hWT
compared to highly active enriched mice expressing PS1 vari-
ants. Notwithstanding the important roles for microglia in regu-
lating NPC proliferation and differentiation in vivo, it should be
noted that other cell populations in the neural stem cell niche
are likely to contribute to the observed phenotypes. For exam-
ple, endothelial cells have been shown to release soluble factors
that stimulate the self-renewal of neural stem cells and alter their
differentiation (Shen et al., 2004). Furthermore, it has become
evident that astrocytes in the subgranular layer express Wnt3,
a factor that plays a critical role in promoting neurogenesis of
hippocampal NPCs by activating the Wnt/b-catenin pathway,
components of which are present in NPCs in vivo (Lie et al.,
2005). Indeed, while it is clear that mutant PS1 microglia CM-
drives NPC differentiation toward astrocytic lineages in vitro,
this appears not to be the case in vivo, leading us to suggest
that the differences in these two settings is a reflection of differ-
ences in factors present within microglia culture medium versus
those derived from other cells within the hippocampal niche.
The mechanism(s) by which expression of FAD-linked mutant
PS1 leads to impairments in proliferation and neuronal differen-
tiation of NPCs in vivo are not fully established. PS1 is the
catalytic subunit of the g-secretase complex responsible for
intramembranous processing of a variety of type I membrane
proteins, including Notch 1, and processing of these substrates
are largely compromised in cells expressing FAD-linked PS1 var-
iants (Moehlmann et al., 2002; Song et al., 1999). It should be
noted that while the Notch signaling pathway has been impli-
cated in microglial activation and cytokine secretion, we have
neither detected the presence of transcripts encoding the Notch
ligand, Jagged 1, nor have we observed any increase in levels of
transcripts encoding the Notch target gene product, Hes1,
following IL-4 activation of purified microglia from PS1hWT or
PS1 mutant mice (data not shown), and hence, we are quite
certain that the effects we have observed are independent of
Notch signaling.
While the bulk of our data point to alterations in levels of micro-
glial-secreted signaling factors that are responsible for the
differences in NPC proliferation and differentiation, it is equally
plausible that cell-intrinsic signaling within NPCs also contribute
to the observed phenotypes in vivo. In this regard, hippocampal
NPCs express receptors and signaling components for the Wnt/
b-catenin pathway, and Wnt3 is sufficient to increase neurogen-578 Neuron 59, 568–580, August 28, 2008 ª2008 Elsevier Inc.esis from these cells in vitro and in vivo (Lie et al., 2005). In this
regard, studies have revealed that both wild-type and FAD mu-
tant PS1 interact with b-catenin in transfected cells and brains
of transgenic mice (Kang et al., 1999) and wild-type PS1 regu-
lates b-catenin stability in vitro and in vivo (Kang et al., 2002).
Finally, it should be noted that Notch and components of the
Notch signaling pathway, including Jagged 1, Delta 1, CSL
(CBF 1/Su(H)/Lag 2), Hes 1 and Hes 5 are expressed in cultured
NPCs and it is conceivable that cross-talk between the Notch
and Wnt/b-catenin signaling pathways (Carlson and Conboy,
2007) could have an impact on the proliferative and differentia-
tive properties of hippocampal NPCs in vivo.
In summary, our data offer strong support for the view that
expression of FAD-linked mutant PS1 impairs proliferation and
neuronal differentiation of hippocampal NPCs by non-cell-
autonomous mechanism(s). Future investigations of the role of
FAD-linked PS1 on adult hippocampal neurogenesis will have
broad implications for understanding the cellular and biochemi-
cal substrates that underlie the signaling events in the hippocam-
pal neurogenic niche during normal aging and in the setting of
age-associated neurodegenerative disorders, such as AD.
EXPERIMENTAL PROCEDURES
See Supplemental Experimental Procedures for detailed methods on Enriched
environment (EE), BrdU injections, tissue processing, BrdU immunostaining,
immunofluorescence, stereology, and organotypic slice cultures.
Transgenic Mice
Male mice expressing human wild-type PS1 (PS1hWT) (line S8–4; Thinakaran
et al., 1996), FAD-linked human PS1DE9 (line S9; Lee et al., 1997) or
PS1M146L (line I5; Lee et al., 1997) were used in this study. Mice were weaned
and either exposed to EE or kept in standard housing conditions for 1 month.
All mice are heterozygous for the transgene. Background strain for these mice
are (C3H/HeJ3C57BL/6J F3)3C57BL/6J n1 (Lee et al., 1997). APP-deficient
mice (Zheng et al., 1995) were maintained as C57BL/6JX 129sv hybrids and
were crossed with mice expressing PS1hWT or PS1DE9 to generate
PS1hWT/APPKO and PS1DE9/APPKO mice, respectively.
Neural Progenitor and Primary Microglial Cell Culture Studies
Neural progenitor cells (NPCs) that give rise to neurospheres were cultured
from dissected hippocampal tissue of 4- to 8-week-old male transgenic lines
according to the described methods with minor modifications (Bull and
Bartlett, 2005; Seaberg and van der Kooy, 2002). See Supplemental Experi-
mental Procedures for enumeration of clonal neurosphere numbers, NPC pro-
liferation, and multipotency assays. Primary cultures of mixed glia cells were
prepared from dissected hippocampal tissue of newborn transgenicmice lines
and then weakly adherent microglia were enriched from these monolayers.
See Supplemental Experimental Procedures for NPC and microglia coculture
studies, measurement of soluble factors in microglia conditioned media using
high-density antibody arrays, quantitative real time-PCR (Q-PCR) analysis of
transcripts encoding soluble factors, and NPC proliferation assays with
purified soluble factors.
Isolation of Adult Hippocampal Microglia
One-month-old male offspring of PS1hWT and FAD-linked PS1 variant trans-
genic lines were housed in EE or maintained in standard housing conditions for
4 weeks. Following exposure to standard or enriched housing conditions, hip-
pocampi were dissected and pooled (n = 6 animals per group), and microglia
were isolated as described (Cardona et al., 2006). Total RNA from the adult
microglial cells was prepared using Trizol Reagent and reverse transcribed
using Superscript III synthesis kit (Invitrogen, Carlsbad, CA) and SYBR green
Neuron
Presenilin 1 Variants Impair Adult NeurogenesisQ-PCRwas performed using certified RT2 Q-PCR primers (SuperArray BioSci-
ences, Boston, MA).
Statistical Analysis
Data are expressed as mean values ± standard error of the mean (mean ±
SEM). All statistical analyses were performed with SPSS. t test or Factorial
ANOVA was performed for all comparisons of quantitative data followed
by Scheffe or Tukey-Kramer post hoc tests, where appropriate. Values of
p < 0.05 were considered to be significant.
SUPPLEMENTAL DATA
The Supplemental Data include ten figures, one table, and Supplemental
Experimental Procedures and can be found with this article online at http://
www.neuron.org/cgi/content/full/59/4/568/DC1/.
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